Shang Su

Dr. Shang Su

The University of Toledo
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Shang SuShang Su
Shang Su
ZYZimo Yang
Zimo Yang
HGHongying Gao
Hongying Gao
HYHaiyan Yang
Haiyan Yang
SZSongbiao Zhu
Songbiao Zhu
YRYu Rao
Yu Rao

5 December 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
QZQiuye Zhao
Qiuye Zhao
TLTianlong Lan
Tianlong Lan
Shang SuShang Su
Shang Su
YRYu Rao
Yu Rao
Poly (ADP-ribose) polymerase-1 (PARP1) is a major member of the PARP superfamily that is involved in DNA damage signalling and other important cellular processes. Here we report the development of a small molecule targeting PARP1 based on the PROTAC strategy. In the MDA-MB-231 cell line, the representative compound 3 can induce significant PARP1 cleavage and programmed cell death.

2 January 2019 in Protein & Cell
Verified
Journal Article
Open access
PDF file
ZAZixuan An
Zixuan An
WLWenxing Lv
Wenxing Lv
Shang SuShang Su
Shang Su
WWWei Wu
Wei Wu
YRYu Rao
Yu Rao

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
YDYajie Ding
Yajie Ding
Shang SuShang Su
Shang Su
WTWeixin Tang
Weixin Tang
XZXiaolei Zhang
Xiaolei Zhang
SCShengyao Chen
Shengyao Chen
WWWei Wu
Wei Wu
Wnt/β-catenin signaling via the β-catenin/TCF complex plays crucial roles in tissue homeostasis. Wnt stimulated β-catenin/TCF complex accumulation in the nucleus regulates cell survival, proliferation, and differentiation through the transcription of target genes. Compared with those in G1, LRP6 receptor activation and cytosolic β-catenin are both up-regulated in G2 cells. However, accumulation of the Wnt pathway negative regulator, AXIN2, also occurs in this phase. Therefore, it is unclear whether Wnt signaling is active in G2 phase cells. Here, we established a bimolecular fluorescence complementation (BiFC) biosensor system for the direct visualization of β-catenin/TCF interaction in living cells. Using the BiFC biosensor and co-immunoprecipitation experiments, we demonstrated the nucleus-localized β-catenin/TCF complex increases during the S and G2 phases, and declines in the next G1 phase. Accordingly, a subset of Wnt target genes was transcribed by the β-catenin/TCF complex during both S and G2 phases. In contrast, transient inhibition of this complex disturbed both cell survival and G2/M progression. Our results suggest that in S-G2 phase cells, Wnt/β-catenin signaling is highly active and functions to ensure cell survival and cell-cycle progression.

6 November 2021 in Cancer Letters
Verified
Journal Article
Closed access
Shang SuShang Su
Shang Su
JCJingchen Cao
Jingchen Cao
XMXiangqi Meng
Xiangqi Meng
RLRuihua Liu
Ruihua Liu
AAAlexandra Vander Ark
Alexandra Vander Ark
XLXiaohong Li
Xiaohong Li

26 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
YZYawei Zhao
Yawei Zhao
Shang SuShang Su
Shang Su
XLXiaohong Li
Xiaohong Li
PTHrP exerts its effects by binding to its receptor, PTH1R, a G protein-coupled receptor (GPCR), activating the downstream cAMP signaling pathway. As an autocrine, paracrine, or intracrine factor, PTHrP has been found to stimulate cancer cell proliferation, inhibit apoptosis, and promote tumor-induced osteolysis of bone. Despite these findings, attempts to develop PTHrP and PTH1R as drug targets have not produced successful results in the clinic. Nevertheless, the efficacy of blocking PTHrP and PTH1R has been shown in various types of cancer, suggesting its potential for therapeutic applications. In light of these conflicting data, we conducted a comprehensive review of the studies of PTHrP/PTH1R in cancer progression and metastasis and highlighted the strengths and limitations of targeting PTHrP or PTH1R in cancer therapy. This review also offers our perspectives for future research in this field.